Ace Glycosylated Hemoglobin Analysis Reagent Group - Taiwan Registration 2f31008df5277f7c3efd2afe2aafd548
Access comprehensive regulatory information for Ace Glycosylated Hemoglobin Analysis Reagent Group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 2f31008df5277f7c3efd2afe2aafd548 and manufactured by Trinity Biotech (Primus Corporation dba Trinity Biotech). The authorized representative in Taiwan is PROGRESSIVE GROUP INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used in conjunction with the Premier HB9210 System for the quantitative evaluation of glycosylated hemoglobin in human microvascular and venous whole blood samples. HbA1C can be used for long-term monitoring of blood glucose in diabetic patients, and is only used for in vitro diagnosis.
B Hematology, pathology, and genetics
B.7470 Analysis of glycosylated hemoglobin
import
Dates and Status
Aug 06, 2012
Aug 06, 2017
Nov 21, 2019
Cancellation Information
Logged out
ๆชๅฑๅปถ่้พๆ่